The Sphere’s success comes as Hollywood is in a bind. Viewers’ habits have been changing over the past decade, giving way to ...

Discover the best Mexican eateries in every state. From local favorites to hidden gems, embark on a culinary journey through ...

After a phase 3 trial win, Madrigal Pharmaceuticals reckons it could succeed where so many other companies have failed, and finally bring a drug to market to treat the liver disease non-alcoholic ...

Madrigal Pharma has become the first drugmaker to claim FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH), an elusive target that has seen many other ...

The latest price target for Madrigal Pharmaceuticals (NASDAQ:MDGL) was reported by Piper Sandler on December 19, 2025. The analyst firm set a price target for $900.00 expecting MDGL to rise to within ...

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers ...

Get the detailed quarterly/annual income statement for Madrigal Pharmaceuticals, Inc. (MDGL). Find out the revenue, expenses and profit or loss over the last fiscal year.

The City of Quincy on Dec. 16 adopted its 2026 final budget, budgeting nearly $13 million in its current general expense fund ...

Globus Medical analysts maintain a 'Moderate Buy' consensus with a $93.11 price target. Learn why GMED stock is bullish ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...